WELL Health Technologies reported third-quarter 2024 revenues of CA$251.7 million, a 23% increase from the previous year, surpassing analyst expectations by 1.6%. However, the company faced a net loss of CA$81.2 million, with a loss per share of CA$0.33, worsening from CA$0.032 in 3Q 2023. Looking ahead, revenue is projected to grow at an average of 8.7% annually over the next three years, slightly below the 9.3% growth forecast for the Canadian healthcare industry.